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Asthma is a chronic, non-curable, multifactorial disease with increasing incidence in industrial
countries. This study evaluates the direct contribution of lung microbial components in allergic
asthma in mice. Germ-Free and Specific-Pathogen-Free mice display similar susceptibilities to House
Dust Mice-induced allergic asthma, indicating that the absence of bacteria confers no protection or
increased risk to aeroallergens. In early life, allergic asthma changes the pattern of lung microbiota,
and lung bacteria reciprocally modulate aeroallergen responsiveness. Primo-colonizing cultivable
strains were screened for their immunoregulatory properties following their isolation from neonatal
lungs. Intranasal inoculation of lung bacteria influenced the outcome of allergic asthma development:
the strain CNCM I 4970 exacerbated some asthma features whereas the pro-Th1 strain CNCM I 4969
had protective effects. Thus, we confirm that appropriate bacterial lung stimuli during early life are
critical for susceptibility to allergic asthma in young adults.
The ISME Journal advance online publication, 3 January 2017; doi:10.1038/ismej.2016.181
Introduction
Allergic asthma is a worldwide problem with rising
prevalence and morbidity in industrialized coun-
tries. Variable airway obstruction is a typical feature
of this disease, caused by chronic eosinophilic
airway inflammation, mucus overproduction, airway
wall remodeling and bronchial hyperactivity. In
allergic asthma, allergen-specific Th2 lymphocytes
cause inflammation and control the synthesis of
allergen-specific IgE, a hallmark of allergic sensitiza-
tion (Kool et al., 2012; Plantinga et al., 2013; Just
et al., 2014). The cause of the asthma epidemic in the
Western world is unclear, but its increased incidence
has been correlated to changes in environment and
gut microbiota (Fujimura and Lynch, 2015).
It has been proposed that the perturbation of early
microbial stimulation in industrialized countries,
due to improved hygiene, excessive antibiotherapy
and dietary changes, results in an aberrant immune
response to innocuous antigens later in life (Wills-
Karp et al., 2001; Noverr and Huffnagle, 2005;
Schuijs et al., 2015). However, the gut dysbiosis
observed in asthma did not obligatory mean a causal
role of gut microbiota in the pathology. Recent
epidemiological and clinical data (Hoskin-Parr
et al., 2013), as well as experimental data obtained
in mouse models (Noverr et al., 2004; Olszak et al.,
2012), support the key role of the microbial environ-
ment. Bacterial colonization of the gut during the
first months of life is critical for the development and
the balance of the immune system: it promotes the
maturation of the epithelial mucosa (Cherbuy et al.,
2010; Tomas et al., 2013, 2015), the establishment of
immune tolerance (Gaboriau-Routhiau et al., 2009;
Cahenzli et al., 2013) and improves stimulation of
the immune system that helps to prevent and/or
resolve infectious diseases (Cerf-Bensussan and
Gaboriau-Routhiau, 2010; De Filippo et al., 2010;
Buffie and Pamer, 2013).
Healthy lungs have historically been considered to
be sterile, but the description of a resident lung
microbiota emerged a few years ago and broke this
dogma. A bacterial community has been described
in healthy human lungs (Charlson et al., 2011;
Erb-Downward et al., 2011). Lung bacteria originate
from the upper respiratory tract and the mouth
(Bassis et al., 2015; Venkataraman et al., 2015). The
question of a stable versus transient colonization of
lung by bacteria remains open (Segal et al., 2013),
but even if the lung microbes are only transited they
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can have major health impact. The composition and
role of the lung microbiota remain largely unknown,
and has mainly been explored using genomic
approaches (Beck et al., 2012; Charlson et al.,
2012). In 2011, Sibley et al. evaluated the cultiva-
bility of the airway microbiome using culture-
enriched molecular profiling and were able to
cultivate 43 of the 48 families detected by deep
sequencing. Using both culture and genomic
approaches, Yun et al. (2014) have shown that the
lung microbiota is diversified through different
environmental conditions and affects lung architec-
ture. The direct contribution of the lung microbiota,
and potential associated dysbiosis, in both the
physiology and pathology of the respiratory tract
remains unclear.
Recent publications suggest that the lung micro-
biota is altered in asthmatic patients. Analysis of 16s
RNA sequences in bronchial lavage from asthmatic
children revealed a highly significant increase of
Proteobacteria (Hilty et al., 2010). Moreover, airway
dysbiosis appears to vary depending on the severity
of the disease (Huang et al., 2015) or corticosteroid
responsiveness (Goleva et al., 2013). The correlation
between asthma and modification of the airway
microbiota composition is now clearly established
(Teo et al., 2015; Smits et al., 2016). Gollwitzer et al.
(2014) demonstrated that microbial signals in the
lung of neonatal mice clearly improve immune
tolerance to House Dust Mite (HDM) allergens via
PD-1/PD-L1 signaling in regulatory T cells and
dendritic cells (DC). Their study established a direct
contribution of microbial components to HDM
induced asthma.
Previous studies proposed that asthma features are
influencing by microbiota based on ovalbumin
challenge model (Herbst et al., 2011; Olszak et al.,
2012) or oral antibiotic treatment (Hill et al., 2012).
The contribution of lung bacterial strains to the
establishment of asthma or their participation in
chronic inflammation has never been addressed by
using HDM challenge. In this study, we demonstrate
that lung bacteria participate in determining the
immune and inflammatory responses to HDM in
neonatal C57BL/6 mice.
Materials and methods
Bacterial strains, media, growth conditions
Lung bacterial strains were isolated from mouse lung
homogenates prepared using an Ultraturax or Tissue
Lyser (Qiagen, Courtaboeuf, France), diluted in Brain
Heart Infusion liquid medium supplemented with
5 g l− 1 of yeast extract, 5mg l− 1 of hemin, 2mg l− 1 of
vitamin K1 and 0.5 g l− 1 of cysteine (yhBHI, all
products are from Sigma-Aldrich, Eurogenetec,
Angers, France) and cultivated on agar yhBHI
medium (GyhBHI), M17, MRS or Mannitol Sel Agar
medium for 24–48 h at 37 °C under aerobic condi-
tions or 5 days at 37 °C in a Freter chamber under
anaerobic conditions. Isolated strains were frozen at
−80 °C in 16% glycerol. Strain identities were
confirmed by mass spectrometry, API gallery (Bio-
mérieux, Craponne, France) and 16S PCR sequen-
cing. Selected strains were deposited at the French
National Collection of Microorganism Cultures
(CNCM) under the name CNCM I 4969 and CNCM I
4970 (patented strains).
Animals and procedures
Animal experiments were approved by the local
ethics committee under the registration number
01553.01. SPF C57BL/6 mice purchased from Janvier
(Le Genest, St Isle, France) were bred and housed
under FELASA SPF conditions in our animal
facilities (IERP, INRA, Jouy-en-Josas, France, or
VIB, Ghent, Belgium). GF C57BL/6 mice were
purchased from CDTA (CNRS, Orleans, France) or
local breeders (INRA) and were bred and housed
under germ-free conditions in Trexler-type isolators
(La Calhène, Vélizy, France) in the Anaxem animal
facilities (INRA). For HDM allergic asthma induc-
tion, 7-day-old pups received 1 μg of HDM (Greer,
Lenoir, NC, USA) or diluent lipopolysaccharide-free
phosphate-buffered saline (PBS) (Lonza, Levallois-
Perret, France) in a volume of 10 μl. They were
challenged 1 week later with 10 μg of HDM (or PBS)
for five consecutive days. In some experiments,
5-day-old pups received 1× 106 bacteria in 10 μl
PBS every 2 days.
Sample collection
Mice were killed by intraperitoneal injection of a
lethal dose of ketamine and xylazine. The left
bronchus was clamped and bronchoalveolar lavage
(BAL) was performed on the right lobes with PBS
1mM EDTA as described (Roux et al., 2011). BAL
supernatants were stored frozen at − 20 °C and
BAL cells were cytocentrifuged (Cytospin 5) on
microscope slides (Superfrost, Thermo Scientific,
Braunschweig, Germany), and then stained with
May-Grünwald and Giemsa. The right lobe was used
for flow cytometry or bacterial enumeration on agar
plates after homogenization with a Tissue Lyser. For
flow cytometry, the right lobe and the respiratory
lymph nodes (RLN) (cervical, maxillary and med-
iastinal LN) were treated with 1mgml− 1 collagenase
D and 0.5 mgml− 1 DNAse I for cell isolation. The left
lobe of the lung was kept frozen at −80 °C until
processing for RNA extraction. For histological
examination, the lungs were fixed with 4% paraf-
ormaldehyde and embedded in paraffin.
Precision-cut lung slides
Precision-cut lung slides (PCLS) were obtained from
fresh lungs using a Krumdieck tissue slicer MD 6000
(Alabama Research and Development, Munford, AL,
USA). The lungs were filled via the trachea with
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RPMI 1.5% low melting point agarose (Invitrogen,
Villebon sur Yvette, France) warmed to 37 °C. After
1 min for solidification, the lungs were placed in
the microtome chamber of the Krumdieck, filled
with cold PBS and cut at a thickness of 200 μM. Two
PCLS per well were then placed at 37 °C, 5% CO2,
in P24 well plates (Nunc, Sigma-Aldrich, Lyon,
France) with 1 ml RPMI 1640 (Gibco, Sigma-
Aldrich, Lyon, France) supplemented with 10%
heat inactivated fetal calf serum (Gibco) and 2mM
L-glutamine (Gibco). The medium was changed
every 30 min during 2 h to remove the low melting
point agarose and one last time after overnight
incubation. PCLS were then co-incubated for 24 h
with lung bacteria. Viability was assessed by
measuring lactate dehydrogenase release (Sigma)
or by MitoTracker Deep Red (ThermoFisher, Ill-
kirch, France) labeling.
Histology
Five-micrometer lung sections were stained with
hematoxylin/eosin/saffron or periodic acid schiff/
alcian blue and photographed using CaseViewer
software (3DHISTECH, Budapest, Hungary).
Gene expression by quantitative reverse transcriptase
PCR
Total RNA was extracted from mouse lung homo-
genates using the NucleoSpin RNA kit (Macherey
Nagel, Düren, Germany) and reverse transcribed
using random primers and 50 U of Reverse Tran-
scriptase (High-Capacity cDNA Archive Kit; Applied
Biosystems by Life Technologies SAS, Villebon Sur
Yvette, France) according to the manufacturer’s
instructions. The primers (Sigma-Aldrich) are listed
in Supplementary Table S1. Quantitative reverse
transcriptase PCR was performed in triplicate for
each gene using an AbiPrism 7000 (Applied Biosys-
tem) and Takyon ROx SYBR MasterMix (Eurogene-
tec) and the data were analyzed using 700 System
SDS software (Applied Biosystem) to determine the
cycle threshold (Ct) values. Messenger RNA (mRNA)
expression was calculated using the ΔCt method and
normalized to the expression of mHPRT.
Flow cytometry
After saturation with anti-CD32/CD16, cells were
incubated with mAbs reactive to mPDCA1 (JF05-
1C2.4.1, conjugated to FITC), MHCII (IA/IE, 2G9 or
M5/114.15.2, FITC or PE), CD103 (M290 or 145-
2D11, PE), CD86 (GL1, FITC), CD11b (M1/70, PerCP
Cy5.5) or CD11c (HL3, Biotin or BV786). For T-cell
staining, cells were incubated with mAbs reactive to
CD4 (L3T4 or RM4-5, FITC or PECy7), CD45.2 (104,
A780), CD3 (145-2C11, PerCP Cy5.5) or CD8 (Ly2,
53-6.8, Biotin or APC). For B-cell staining, cells were
incubated with mAbs reactive to CD19 (1D3, APC),
B220 (RA36B2, APC), CD45.2 (104, A780), CD5
(53-7.3, BV421) or CD23 (B3B4, FITC). All mAbs were
purchased from BD Biosciences (San Jose, CA, USA)
except for mPDCA1 (Miltenyi Biotec, Paris, France).
APC-conjugated streptavidin (BD Biosciences) was
used to label biotin Abs. At least 2×106 events
were acquired using an Accuri or Fortessa FACS
(BD Biosciences) and analyzed using FlowJo Sofware
v7.5 (Tree Star Inc., Ashland, OR, USA).
Cytokine and Ig enzyme-linked immunosorbent assay
The cytokines IL-5, IL-10, IL-12p70, IL-17a or
IFNγ (Mabtech, Nacka Strand, Sweden) and TSLP
(eBiosciences, Paris, France) were quantified by
enzyme-linked immunosorbent assay according to
the manufacturer’s instructions. Individual mouse
sera were assayed for IgE and IgG1 (eBiosciences)
according to the manufacturer’s instructions.
Statistical analysis
Non-parametric Mann–Whitney (comparison of two
groups, n⩾ 4) or ANOVA Tukeys multiple compar-
ison test (42 groups) was used to compare unpaired
values (GraphPadPrism software, GraphPad Soft-
ware, Inc., San Diego, CA, USA). Significance is
represented: *Po0.05; **Po0.01; ***Po0.001; and
****Po0.0001.
Results
Allergic asthma is not modified in germ-free mice
Asthma sensitivity was evaluated both in Germ-Free
(GF) and Specific-Pathogen-Free (SPF) neonatal mice
(Figure 1a). On day 0, 7-day-old neonates were
intranasally sensitized with 1 μg of HDM or PBS
diluent (PBS). They were challenged 1 week later
with 10 μg of HDM or PBS intranasally on five
consecutive days. All mice were killed, when they
were 23 days old (5 days after the last challenge
dose) to assess the inflammatory and immune
responses in young adults (Figures 1b–d). In vivo
lung function measurements were not feasible at that
age. Both GF and SPF HDM challenged mice showed
similar levels of inflammatory cell recruitment near
the airway, bronchus epithelium thickening and
myofibroblasts by hematoxilin eosin safran colora-
tion of lung sections (Figure 1b). We did not observe
any striking differences in lung structure, airway
epithelium thickness or bronchus number between
GF PBS- and SPF PBS-treated mice (Figure 1b),
although the lungs of GF mice seemed to have fewer,
larger alveoli, as previously published (Yun et al.,
2014). The total number of cells recovered from BAL
was greater after HDM treatment (Figure 1c, PBS vs
HDM: Po0.05 for GF; Po0.01 for SPF). We observed
a type 2 immune (T2) signature after HDM treatment,
as shown by the presence of eosinophils and IL-5 in
BAL (Figure 1c, PBS vs HDM: Po0.01 for both GF
and SPF), IgE in sera (Figure 1c, PBS vs HDM:
Po0.05 for GF, Po0.01 for SPF), and IL-5 and IL-10
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secretion by RLN cells re-stimulated in vitro with
RPMI medium supplemented with HDM (Figure 1d,
Po0.01 (both) for GF; Po0.001 (IL-5) and Po0.05
(IL-10) for SPF). HDM efficiently induced allergic
asthma, with an equivalent magnitude of T2
immunity and inflammatory response in GF and
SPF mice, despite higher variability of IgE levels in
GF sera.
We observed that some innate genes showed
different patterns of expression at steady state
Figure 1 HDM-induced asthma is not exacerbated in GF mice. (a) Schematic outline of the experimental approach. Animals were killed
on d16. (b) Lungs were fixed, embedded in paraffin and sectioned at a thickness of 5 μm. Lung sections were stained with hematoxylin–
eosin–saffron (HES) and photographed using Case Viewer software. One representative section per group is shown (n=6 GF mice, n=11
SPF mice). The scale bar represents 50 μm. (c) BAL cells were enumerated, cytocentrifuged and stained with May–Gründwald–Giemsa.
Eosinophils were enumerated and expressed as the percentage of total BAL cells. BAL IL-5 and serum IgE levels were measured by
enzyme-linked immunosorbent assay (ELISA). Data are shown individually and as the mean± s.e.m. (d) Individual respiratory lymph node
(RLN) cells were isolated and cultivated 72 h in RPMI with or without HDM. IL-5 and IL-10 levels in the supernatants were measured by
ELISA. The RPMI±HDM values for the same mice are connected with a dotted line. Data are shown individually and as the mean± s.e.m.
(a–d) All data represent one of two independent experiments (n=4–8 mice per group).
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between GF and SPF mice: the level of TSLP mRNA
was higher in GF mice, whereas IL-10, IFNγ, CCL11
and Muc5AC mRNA levels were higher in SPF mice
(Supplementary Figure S1, Po0.05 for IL-10,
Po0.01 for all other genes). We next evaluated the
number of lung immune cells, such as DC, T and B
cells, by flow cytometry (Supplementary Figures
S2A–D). All subpopulations of DCs, including
plasmacytoid DCs (pDC) and the two subsets of
conventional DCs (cDC) CD11b+ CD103− (CD11b+) and
CD11b− CD103+ (CD103+), were present at the same
levels in both GF and SPF lungs. The levels were also
similar for CD4 and CD8 T cells, and B cells.
Altogether, our results show differences in
mRNA levels for some innate genes between GF
and SPF mice, but no marked differences of lung
physiology or immune cell numbers (except for
higher BAL cellularity for SPF mice, Figure 1c,
Po0.01). HDM-induced allergic asthma was
neither reduced nor exacerbated in GF mice. The
absence of bacteria had no obvious influence on
HDM pathology.
Asthma influences lung microbiota during the neonatal
period
We tested whether HDM-induced asthma influences the
viable bacteria amount in the lung. We used samples
from embryonic day 19.5 and GF mice as sterile
controls for our culture protocol. After birth, bacteria
gradually arrived to the lung (Figure 2a). The bacteria
can be cultivated both in aerobic and anaerobic
conditions (data not shown). We never obtained
cultivable bacteria from individual BAL of SPF neonatal
mice (Figure 2a) nor purified enough bacterial DNA for
16S sequencing (data not shown). We succeeded in
recovering viable bacteria from the lungs of SPF mice
starting from 3 days after birth, and the number of lung
bacteria increased significantly each week until wean-
ing after 21 days (Figure 2a; Po0.01 and Po0.001). We
isolated more than 20 bacterial strains from neonatal
lungs: a majority of members within the Firmicutes
phylum (Staphylococcus, Streptococcus, Enterococcus,
Listeria, Lactobacillus) and some from the Proteobac-
teria phylum (Escherichia coli, Proteus mirabilis)
(Supplementary Table S2).
Figure 2 Lung microbiota is modified during HDM induced asthma. (a) BAL or lung homogenates were incubated 24 h on GyhBHI plates
and the bacteria enumerated as colony-forming units (CFU per ml of BAL (from 21-day-old GF or SPF mice) or grams of lung (from
embryonic day 19.5 embryos or 3, 7, 14 or 21-day-old neonates). (b) Schematic outline of the experimental approach for panel (c) (days of
killing are illustrated with starts). (c) Lung homogenates were incubated 24 h on GyhBHI (to enumerate all bacteria CFU) and Mannitol Sel
agar plates (to enumerate Staphylococcus CFU). (a–c) All data represent one of three independent experiments (n=5–10 mice per group).
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To evaluate the impact of HDM treatment on the
lung microbiota, mice were killed at different time
points as illustrated by stars on the time line in
Figure 2b. The number of bacteria recovered in non-
selective GyhBHI medium significantly increased on
d1 and d7 (Figure 2c, Po0.05). This tendency was
not significant on d11, and the number of colony-
forming units (CFU) reached similar levels for HDM
and SPF mice on d16. Staphylococci levels were
particularly high after HDM treatment (Figure 2c,
selective Mannitol Sel Agar plates). Thus, HDM
treatment influenced the composition of the lung
microbiota during the neonatal period.
Lung bacteria influence asthma features
We next sought to screen the 20 lung bacterial strains
for their capacity to differentially promote cytokine
production by PCLS. Of the 20 strains tested,
7 induced significant production of cytokine
(Supplementary Table S2) and CNCM I 4969 and
CNCM I 4970 (patented strains, Gram+ coccus)
displayed specific immunostimulatory properties
(Figure 3). After 24 h of co-culture with GF PCLS,
CNCM I 4969 stimulated the secretion of IL-12p70
and decreased the basal level of TSLP (Figure 3,
Po0.01). CNCM I 4970 significantly increased the
amount of TLPS, IL-10, IL-17a and IL-12p70 released
into PCLS supernatants (Figure 3, Po0.001 for TSLP,
Po0.01 for IL-10 and IL-12p70, and Po0.05 for
IL-17a). The secretion of IL-5 tends to be higher in
CNCM I 4970-stimulated cells compared with non-
stimulated cells, but does not reach significant level
(P=0.0625). Altogether, CNCM I 4969 induced a
type 1 cytokine profile whereas CNCM I 4970
(a member of the Staphylococcus genus, whose
levels were higher after HDM treatment) induces
secretion of the majority of cytokines tested (TSLP,
IL-10, IL-17a and IL-12p70).
We next investigated whether these two immuno-
modulatory bacteria isolated from the neonatal lung
microbiota could affect the severity of HDM-
triggered asthma in SPF mice. Neonates received
106 CFU of CNCM I 4969 or CNCM I 4970
(10 μl intranasally every 2 days starting at d2), and
the readouts of asthma features were explored after
weaning in young adult mice (23 days old) as
illustrated in Figure 4a. Nasal administration
enabled bacterial delivery to the lungs, as verified
by the detection of CFDA-SE labeled strains in BAL
and lungs (Supplementary Figure S3). HDM
treatment induced a small, but reproducible
(n=3 experiments), growth delay in neonates
(Figure 4b, PBS vs HDM, Po0.001). Indeed, during
the challenge phase (d7 to d11), HDM-treated
neonates gained less weight. CNCM I 4969 adminis-
tered alone had no significant effect on the growth of
the pups. CNCM I 4970 alone negatively affected
weight gain (Figure 4b, PBS vs CNCM I 4970). This
result was obtained for two of three experiments
(data not shown). In the HDM groups, CNCM I 4969
protected the mice against the growth delay
(Figure 4b, Po0.001) whereas CNCM I 4970 wor-
sened it (Figure 4b, Po0.05). We observed fewer
infiltrating cells in BAL from the CNCM I 4969+HDM
group (Figure 5a, CNCM I 4969+HDM group vs
HDM, Po0.001), and the percentage of eosinophils
was lower (Figure 5a, Po0.05). The challenge with
Figure 3 Ex vivo immunomodulation profiles of CNCM I 4969 and CNCM I 4970. Precision-cut lung slices (PCLS) of adult GF lungs were
cultivated ex vivo for 24 h in supplemented RPMI alone (medium) or with 50 CFU of the two strains, CNCM I 4969 and CNCM I 4970,
isolated from healthy neonatal lungs. Cytokines were measured in PCLS supernatants. Data represent two pooled independent
experiments (n=9 mice per group). In total, four independent experiments were performed with similar results (n=4–5 mice per group
per experiment).
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HDM increased the infiltration of neutrophils and
lymphocytes (Figure 5a, Po0.01) that remained
unchanged in the presence of our strains. The strains
CNCM I 4970 significantly increased the basal level
of neutrophils and lymphocytes (Figure 5a, PBS vs
CNCM I 4970, Po0.05 and Po0.01). In our model,
the response is due to eosinophil recruitment rather
than neutrophil. CNCM I 4970 increased IL-5 levels
in PBS-treated mice (Figure 5a, Po0.05) but they
were similar in the HDM and CNCM I 4970+HDM
groups. The basal level of IgE was increased by both
strains, in the absence of HDM (Figure 5b, PBS vs
CNCM I 4970 and PBS vs CNCM I 4969, Po0.01).
The treatment with HDM led to a higher amount of
serum IgE (Figure 5b, HDM vs PBS, Po0.05) and this
HDM-induced IgE was worsened by CNCM I 4970
+HDM (Figure 5b, HDM vs CNCM I 4970+HDM,
Po0.01). The serum IgE levels were not different in
HDM and in CNCM I 4969+HDM, thus indicating
that CNCM I 4969 has no impact on HDM-induced
IgE. IgG1 levels were increased in the presence of
HDM plus each strains (Figure 5b, HDM vs CNCM I
4970+HDM, Po0.01; HDM vs CNCM I 4969+HDM,
Po0.05). In RLN supernatants, IL-5 and IL-10
production was significantly lower in the CNCM I
4969+HDM group than in the HDM group (Figure 5c,
Po0.05), suggesting reduced type 2 immune
priming.
The lungs from HDM-treated mice showed perivas-
cular immune infiltrates, myofibroblast proliferation
(Figure 6a, hematoxilin eosin safran staining), mucus
production (Figure 6a, periodic acid schiff/alcian blue
staining) and a thickened epithelium relative to PBS-
treated mice (Figure 6b, Po0.0001). A similar pattern of
inflammatory lesions was observed for the CNCM I
4970 group, which increased moderately upon HDM
challenge. In contrast, CNCM I 4969 did not cause lung
inflammation by itself and even reduced the extent of
the inflammatory reaction in the tissue upon HDM
challenge. All features were markedly reduced relative
to the HDM or CNCM I 4970+HDM groups (Figures 6a
and b, Po0.0001). Thus, inoculation with CNCM I 4969
protected mice from HDM-induced airway disease.
We obtained an intermediate profile when we co-
administered CNCM I 4969 and CNCM I 4970. The
mice were not protected against the growth delay
(Figure 7a, HDM vs CNCM I 4969+4970+HDM=NS).
Serum IgE and BAL IL-5 levels were similar
(Figure 7b), but BAL cellularity was reduced
(10.39±0.45×105 in HDM vs 7.32±0.75×105 in
CNCM I 4969+4970+HDM, Po0.01) as well as the
percentage of BAL eosinophils (Figure 7b, Po0.05).
Figure 4 Bacterial intervention can modulate asthma features in SPF mice. (a) Schematic outline of the experimental approach. Animals
were killed on d16. (b) Mice were weighed daily. The growth curves are expressed as the mean± s.e.m. of individual weights (normalized
to the initial weight on day -2) for n⩾5 mice per group and represent one of three independent experiments (n=5–10 mice per group).
Tukey’s multiple comparison test, repeated measures one-way ANOVA was used for comparison of the growth curves.
Bacteria isolated from lung modulate asthma
A Remot et al
7
The ISME Journal
IL-5 levels were reduced in RLN supernatants after
in vitro HDM re-stimulation (Figure 7c, Po0.01),
reflecting reduced type 2 immune priming. Finally,
histological examination of lung tissue revealed
moderate inflammation, with a profile comparable to
the HDM group (Figure 7d vs Figure 6). CNCM I 4969
appeared to attenuate some enhanced asthma features
induced by CNCM I 4970 alone. Note that the
strain CNCM I 4967 (Lactobacillus spp), also isolated
from mouse lung, had neutral effect on HDM-
Figure 5 CNCM I 4969 decreases some type 2 immune features whereas CNCM I 4970 worsens it. SPF mice were treated as described in
Figure 4. (a) BAL cells were enumerated, cytocentrifuged and stained with May–Gründwald–Giemsa. Eosinophils, neutrophils and
lymphocytes were enumerated and expressed as the percentage of total BAL cells. BAL IL-5 levels were measured by enzyme-linked
immunosorbent assay (ELISA). (b) Serum IgE and IgG1 levels were measured by ELISA. (a, b) Data are shown individually and as the
mean± s.e.m. (c) Individual respiratory lymph node (RLN) cells were isolated and cultivated 72 h in RPMI with or without HDM. IL-5 and
IL-10 levels in the supernatants were measured by ELISA. The RPMI±HDM values for the same mice are connected with a dotted line.
(a–c) All data represent one of three independent experiments (n=5–10 mice per group).
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induced asthma (Supplementary Table S2 and data not
shown).
Altogether, our results show that forced inocula-
tion of lung bacteria influences the severity of HDM-
induced allergic asthma: CNCM I 4970 exacerbated
some asthma features whereas CNCM I 4969 seemed
to have a protective effect.
Discussion
Our study provides evidence for a reciprocal influence
between lung bacteria and asthma in neonatal mice.
Our data underline the bacterial hypothesis in asthma
(Figure 8) as the early lung bacteria environment can
worsen or attenuate asthma features.
We provide evidence for the presence of living
bacteria in healthy mouse lungs. The number of
viable bacteria increased slightly, but significantly,
within the first 2 weeks. To our knowledge, only one
other study has described the culture of living
bacterial strains from adult mouse lungs (Yun
et al., 2014). In agreement with this study, we also
found members of Enterobacteria and Firmicutes.
Lung microbiota has been mostly investigated using
genomic tools. Here, we used bacterial culture to
further study the functional and immunomodulatory
properties of lung bacteria.
Figure 6 CNCM I 4969 protects against lung inflammation whereas CNCM I 4970 worsens it. SPF mice were treated as described in
Figure 4. (a) Lung histology was assessed as described in Figure 1. Lung sections were stained with hematoxylin–eosin–saffron (HES, first
two rows, enlargement × 20 and ×60) or periodic acid–Schiff and alcian blue (PAS/AB, bottom two rows, enlargement × 60 and ×80). One
representative section per group is shown. (b) Epithelium thickness was measured using Case Viewer software. In total, 100 measures per
group are plotted on the graph. They correspond to the analysis of four mice per group. Five representative bronchi were selected for each
mouse and four measurements were performed per bronchus (up, down, left, right side). (a, b) All data represent one of two independent
experiments (n=5–10 mice per group).
Bacteria isolated from lung modulate asthma
A Remot et al
9
The ISME Journal
The presence of the microbiota obviously influ-
ences local lung physiology and immunity. We
found that innate mRNA markers were differentially
expressed at steady state between the lungs of GF
and SPF mice and that BAL cellularity was higher is
SPF mice. Histological examination of lung slices
showed no major defect in the lungs of GF mice. On
the contrary to what we observed in lung, the gut
microbiota triggers extensive remodeling of the
epithelium of the small and large intestines (El
Aidy et al., 2012; Tomas et al., 2013; Hoffmann et al.,
2016). One important difference between gut and
lung epithelia is their renewal, which is very active
in the gut (Sancho et al., 2004). The presence of stem
and proliferative daughter cells allows constant
reshaping of the gut to face a highly variable luminal
Figure 7 CNCM I 4969 and 4970 induce an intermediate inflammatory profile when given together. SPF mice were treated as described
in Figure 4 but the two strains were inoculated together. (a) Mice were weighed daily. The growth curves are expressed as the mean± s.e.
m. of individual weights (normalized to initial weight at day -2). (b) Serum and BAL responses were analyzed as described in Figures 5a
and b. Data are shown individually and as the mean± s.e.m. (c) IL-5 was measured in RLN supernatants as described in Figure 5c. The
RPMI±HDM values for the same mice are connected with a dotted line. (d) Lung histology was assessed as described in Figure 1. Lung
sections were stained with hematoxylin–eosin–saffron (HES) or Periodic acid–Schiff and alcian blue (PAS/AB). One representative section
(enlargement × 60) per group is shown. (a–d) All data represent one experiment with n=7–8 mice per group.
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environment (Peifer, 2002; Joly et al., 2009; Kaiko
and Stappenbeck, 2014). For example, gut epithelial
cell turnover is an efficient and effective mechanism
for pathogen expulsion (Cliffe et al., 2005). The low-
level renewal of lung cells may be linked to the low
influence of the microbiota on its structure.
The number of lung DC recovered from the lungs
of GF and SPF mice in our experiments was similar,
in agreement with Gollwitzer et al. (2014). These
authors have also observed higher expression of
CD40 and PD-L1 DC markers in 8-day-old SPF mice,
showing a more mature phenotype in the presence of
microbes. We have also found similar numbers of
lung B and T lymphocytes, but did not assess the
different helper T-cell subsets that have been shown
to be regulated by the microbiota (Gollwitzer et al.,
2014; Ohnmacht et al., 2015). Gollwitzer et al. (2014)
reported no difference in lung DC and CD4 T cells
frequency in GF and SPF mice following HDM
exposure. In our hands, the same conclusion
remained true (data not shown, one experiment).
GF mice have altered T- and B-cell numbers in the
gut (Macpherson and Harris, 2004; Hooper and
Macpherson, 2010). This is not the case in the lung.
We hypothesize that lung regulatory mechanisms are
less strongly affected by the microbiota, possibly due
to a lower bacterial load: 1012 per gram in the colon
(Costello et al., 2009; Marchesi, 2011) vs 104 per
gram in the lung (Figure 3a). Some bacterial families
specifically affect gut immunity and physiology
(Wrzosek et al., 2013; Miquel et al., 2015b; Tomas
et al., 2015). For example, segmented filamentous
bacteria increase Th17 (Lécuyer et al., 2014). It is
possible that family-specific regulation also occurs in
the lung, as we observed different immune-
regulating properties ex vivo of different bacterial
strains.
Bacteria can be ranked into functional cores
according to their function (Lozupone et al., 2012)
and it is well described that beneficial or detrimental
effects of bacteria are specific to the strains con-
sidered (Miquel et al., 2015a; Peres et al., 2015). It
may be instructive to link the effects of lung bacteria
to their metabolic activity (Miquel et al., 2015b).
Indeed, we observed in vitro short-chain fatty acid
production by the 20 strains that we studied: mainly
acetate (5–60mmol l−1), and low levels of propionate
and butyrate (o 5mmol l−1) for some strains (data
not shown). CNCM I 4969 and CNCN I 4970 produce
the same amount of acetate (5–6mmol l− 1) and no
propionate or butyrate in vitro so it is unlikely that
the difference observed on asthma pathology is due
to a difference in short-chain fatty acid production.
The lung microbiota enters the airway within a
few days and others have suggested that its composi-
tion stabilizes after 2–3 months in infants (Marsland,
2013). During this primocolonization process, the
neonatal period represents a window of suscept-
ibility to infections by pathogens, or the develop-
ment of non-infectious diseases such as allergic
asthma. Early and chronic exposure to microbial
products such as endotoxin has been demonstrated
to prevent allergic asthma in children growing up in
a dairy farm (Schuijs et al., 2015). Endotoxins reduce
the production of DC-activating cytokines by epithe-
lial cells, thus suppressing type 2 immunity to HDM
(Schuijs et al., 2015). Here, early administration of
either pro-type 1 or pro-type 2 strains modulated
aeroallergen responsiveness. Although we were able
to reduce the type 2 immune response with CNCM I
4969, we did not observe increased production of type
1 cytokines IL-12p70 or IFNγ in RLN supernatants or
BAL fluids (data not shown). TSLP levels in neonatal
BAL fluids were under our detection limit. We also
observed the presence of IL-17a in the CNCM I 4970
group samples, suggesting that this strain not only
activated type 2 immunity but also the Th17 response.
This was not the case for CNCM I 4969.
The administration of CNCM I 4969 or CNCM I
4970 in SPF mice did not change the frequency of
lung DC and T cells observed after HDM challenge
(data not shown, one experiment). The mechanism
underpinning the CNCM I 4969 protective effects
requires further investigations. When we inoculated
CNCM I 4969 during the HDM challenge (d8) instead
of before the sensitization (d2), we lost the protective
effect of the strain (Supplementary Figure S4). We
believe the timing for efficient CNCM I 4969-driven
Figure 8 Lung microbiota is an early life determinant of susceptibility to allergic asthma. Lung bacteria environment affects lung
physiology and immunity, and the equilibrium between the host and its microbiota influences microbiota composition and asthma
features.
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attenuation to be crucial (Supplementary Figure S4).
Our observations are in accordance with early life as
a high susceptibility period for bacterial priming of
the lung. The exploration of the influence of
microbiota on lung immunity and the potential
dysbiosis of microbial communities constitute a
new and promising area of research, which will
have an impact on the prevention and management
of pulmonary diseases such as asthma.
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